Atossa Therapeutics, Inc.(NasdaqCM:ATOS) added to Russell 2500 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | -6.84% |
|
-8.40% | +23.86% |
02/07 | Atossa Therapeutics Names Heather Rees CFO | MT |
02/07 | Atossa Therapeutics, Inc. Appoints Heather Rees as Chief Financial Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.86% | 14Cr | |
+18.97% | 4.53TCr | |
+41.98% | 4.04TCr | |
-10.06% | 3.79TCr | |
+31.15% | 3.18TCr | |
-7.79% | 2.77TCr | |
+13.32% | 2.65TCr | |
+43.05% | 1.4TCr | |
+31.28% | 1.24TCr | |
-7.41% | 1.13TCr |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics, Inc.(NasdaqCM: ATOS) added to Russell 2500 Growth Index